
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A plant biotech start-up in London is seeking a postgraduate Scientist (Level II) to lead their in-house Discovery team. Candidates should have a PhD in plant biology or similar field and be skilled in molecular biology. This role focuses on pioneering research that aims to enhance crops' resistance to diseases. The position offers competitive benefits, including share options and a 10% annual bonus based on milestones.
Resurrect Bio is a VC-backed plant biotech start-up, discovering how to make crops resistant to disease using gene editing. We fix the immune system of crop species. We have a unique pipeline and platform for discovering resistance genes in crops which have been defeated by pathogens and pests. We then resurrect (restore) those resistance genes to make the crop resistant again, without introducing any new DNA to the crop.
We’re focussed on delivering for the world’s farmers a better way to protect their plants, using the crop’s own immune system instead of spraying chemicals. This will enable them to increase food production, reduce land for agriculture and help mitigate climate change.
In December 2021, Resurrect Bio was spun out of the top institute for molecular plant microbe interactions, The Sainsbury Lab, Norwich. Since then, we have attracted financial support from several renowned VCs, as well as UK Government grant funding.
We are seeking a postgraduate Scientist (Level II) to join us at our lab in White City, London. This job will help lead the in‑house Discovery team and will report to the Lead Biologist.
This role will cross both our current screening platform and work on helping to develop the platform further. A PhD in a relevant field is expected, with specific experience in plant science desired.
This role uses blind recruitment practices to reduce unconscious bias in our hiring process. The system identifies information such as names, photos, and personal details are removed during initial screening to ensure candidates are evaluated solely on their skills and experience. We are an equal opportunities employer committed to building a diverse and inclusive workplace.
Applications will close end November 2025.